Improved immunodetection of human papillomavirus E7

Experimental and Molecular Medicine

Volumn 34, Issue 6, 2002, Pages 496-499

  Jeon, Ju Hong ^a   Cho, Sung Yup ^a   Kim, Chai Wan ^a   Shin, Dong Myung ^a   Kwon, Joon Cheol ^a   Choi, Kyung Ho ^a   Kim, In Gyu ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Glutaral; Immunoblotting; Immunologic techniques; Oncogene proteins, viral, papillomavirus, human

Indexed keywords

GLUTARALDEHYDE; ONCOPROTEIN; RETINOBLASTOMA PROTEIN; VIRUS PROTEIN;

ARTICLE; CARCINOGENESIS; CELL TRANSFORMATION; DIAGNOSTIC ACCURACY; HELA CELL; HUMAN PAPILLOMAVIRUS E7; IMMUNOBLOTTING; IMMUNODETECTION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL PROCEDURES; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA; VIRUS DETECTION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0037207238     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2002.69     Document Type: Article

References (14)

1. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802
2. DenHollander N, Befus D. Loss of antigens from immunoblotting membranes. J Immunol Methods 1989;122:129-35
3. Dyson N, Howley PM, Munger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989;243:934-7
4. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-20
5. Hauri HP, Bucher K. Immunoblotting with monoclonal antibodies: importance of the blocking solution. Anal Biochem 1986;159:386-9
6. Hoffman WL, Jump AA, Kelly PJ, Ruggles AO. Binding of antibodies and other proteins to nitrocellulose in acidic, basic, and chaotropic buffers. Anal Biochem 1991;198:112-8
7. Johnson TJ. Glutaraldehyde fixation chemistry: oxygen-consuming reactions. Eur J Cell Biol 1987;45:160-9
8. Mizzen CA, Cartel NJ, Yu WH, Fraser PE, McLachlan DR. Sensitive detection of metallothioneins-1, -2 and -3 in tissue homogenates by immunoblotting: a method for enhanced membrane transfer and retention. J Biochem Biophys Methods 1996;32:77-83
9. Munger K, Phelps WC. The human papillomavirus E7 protein as a transforming and transactivating factor. Biochim Biophys Acta 1993;1155:111-23
10. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-36
11. Swerdlow PS, Finley D, Varshavsky A. Enhancement of immunoblot sensitivity by heating of hydrated filters. Anal Biochem 1986;156:147-53
12. Van Eldik LJ, Wolchok SR. Conditions for reproducible detection of calmodulin and S100 beta in immunoblots. Biochem Biophys Res Commun 1984;124:752-9
13. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9
14. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92:690-8